Research with stem cells is ongoing. Scientists have reported that they are ready to conduct the first clinical trial of transfusion of artificial blood. Soon the first patients will receive a biological fluid based on stem cells, reports The Times.
Mark Turner, medical Director Scottish national blood transfusion service, who heads the project at Edinburgh University reports that it is now possible creation of red blood cells suitable for transfusion. Previously on artificial blood had only dreamed of. By 2016 specialists plan to use technology everywhere, and in the future to completely switch to artificial blood.
The first tests will take place on patients with thalassemia major. This disease requires regular blood transfusions. The first dose will be only 5 ml and allow to assess the reaction of the patient's body. Possible in the future and complete the transition to the red blood cells from the laboratory, says Professor mark Turner.